ArticleCancer research communications2025

Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study.

William C Reinhold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.